Drug allergy and hypersensitivity: Still a hot topic

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 64, Issue 2, 2009, Pages 179-182

  Bousquet, P J ^a,b   Demoly, P ^b   Romano, A ^c,d  

^a GHU Caremeau   (France)

^b HÔPITAL ARNAUD DE VILLENEUVE   (France)

^c UCSC Allergy Unit   (Italy)

^d OASI RESEARCH INSTITUTE IRCCS   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; ACETYLSALICYLIC ACID; ANTIFUNGAL AGENT; ATAZANAVIR; BETA LACTAM ANTIBIOTIC; CETUXIMAB; CHONDROITIN SULFATE; COTRIMOXAZOLE; ENFUVIRTIDE; ETORICOXIB; HEPARIN; IMMUNOGLOBULIN E; LOW MOLECULAR WEIGHT HEPARIN; MEROPENEM; NEVIRAPINE; NONSTEROID ANTIINFLAMMATORY AGENT; OSELTAMIVIR; PENICILLIN G; TRIFLUSAL; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ANAPHYLAXIS; DATA BASE; DRUG APPROVAL; DRUG HYPERSENSITIVITY; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; EDITORIAL; HEALTH CARE COST; HUMAN; PRIORITY JOURNAL; RISK ASSESSMENT; SKIN TEST; STANDARDIZATION;

DRUG HYPERSENSITIVITY; HUMANS; PHARMACEUTICAL PREPARATIONS;

EID: 58649109126     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2008.01960.x     Document Type: Editorial

References (44)

1. Bousquet J, Chiron R, Humbert M. Biologics in asthma: difficulties and drawbacks. Expert Opin Biol Ther 2008 8 : 1921 1928.
2. Giezen TJ, Mantel-Teeuwisse AK, Straus SM, Schellekens H, Leufkens HG, Egberts AC. Safety-related regulatory actions for biologicals approved in the United States and the European Union. JAMA 2008 300 : 1887 1896.
3. Chung CH, Mirakhur B, Chan E, Le QT, Berlin J, Morse M et al. Cetuximab-induced anaphylaxis and IgE specific for galactose-alpha-1,3- galactose. N Engl J Med 2008 358 : 1109 1117.
4. Benucci M, Manfredi M, Demoly P, Campi P. Injection site reactions to TNF-alpha blocking agents with positive skin tests. Allergy 2008 63 : 138 139.
5. Zhang Z, Weiwer M, Li B, Kemp MM, Daman TH, Linhardt RJ. Oversulfated chondroitin sulfate: impact of a heparin impurity, associated with adverse clinical events, on low-molecular-weight heparin preparation. J Med Chem 2008 51 : 5498 5501.
6. Kishimoto TK, Viswanathan K, Ganguly T, Elankumaran S, Smith S, Pelzer K et al. Contaminated heparin associated with adverse clinical events and activation of the contact system. N Engl J Med 2008 358 : 2457 2467.
7. Greinacher A, Warkentin TE. Contaminated heparin. N Engl J Med 2008 359 : 1291 1292 author reply 3.
8. Kakkar AK, Bonnefoi M. Contaminated heparin. N Engl J Med 2008 359 : 1292 1293 author reply 3.
9. Brockow K, Jofer C, Behrendt H, Ring J. Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients. Allergy 2008 63 : 226 232.
10. Hirschfeld G, Weber L, Renkl A, Scharffetter-Kochanek K, Weiss JM. Anaphylaxis after Oseltamivir (Tamiflu) therapy in a patient with sensitization to star anise and celery-carrot-mugwort-spice syndrome. Allergy 2008 63 : 243 244.
11. Hur GY, Choi GS, Park HJ, Ye YM, Park HS. Anaphylactic shock induced by Codonopsis lanceolata, traditional Chinese medicine in a patient with allergic rhinitis. Allergy 2008 63 : 1406 1407.
12. de Padua CA, Uter W, Geier J, Schnuch A, Effendy I. Contact allergy to topical antifungal agents. Allergy 2008 63 : 946 947.
13. Goujon-Henry C, Hennino A, Nicolas JF. Do we have to recommend not using oat-containing emollients in children with atopic dermatitis? Allergy 2008 63 : 781 782.
14. Yates AB. Management of patients with a history of allergy to beta-lactam antibiotics. Am J Med 2008 121 : 572 576.
15. Idsoe O, Guthe T, Willcox RR, de Weck AL. Nature and extent of penicillin side-reactions, with particular reference to fatalities from anaphylactic shock. Bull World Health Organ 1968 38 : 159 188.
16. Romano A et al. Benzylpenicillin skin testing is still important in diagnosing immediate hypersensitivity reactions to penicillin. Allergy 2009 64 : 249 253.
17. Weber-Mani U, Pichler WJ. Anaphylactic shock after intradermal testing with betalactam antibiotics. Allergy 2008 63 : 785.
18. Kvedariene V, Demoly P. The need for a biological diagnosis of penicillin allergy. Clin Exp Allergy 2008 38 : 869 871.
19. de Weck AL, Sanz ML, Gamboa PM, Aberer W, Bienvenu J, Blanca M et al. Diagnostic tests based on human basophils: more potentials and perspectives than pitfalls. Int Arch Allergy Immunol 2008 146 : 177 189.
20. Abuaf N, Rostane H, Rajoely B, Gaouar H, Autegarden JE, Leynadier F et al. Comparison of two basophil activation markers CD63 and CD203c in the diagnosis of amoxicillin allergy. Clin Exp Allergy 2008 38 : 921 928.
21. Romano A, Viola M, Guéant-Rodriguez RM, Gaeta F, Valluzzi R, Guéant JL. Brief communication: tolerability of meropenem in patients with IgE-mediated hypersensitivity to penicillins. Ann Intern Med 2007 146 : 266 269.
22. Romano A, Viola M, Guéant-Rodriguez RM, Gaeta F, Pettinato R, Guéant JL. Imipenem in patients with immediate hypersensitivity to penicillins. N Engl J Med 2006 354 : 2835 2837.
23. Atanaskovic-Markovic M, Gaeta F, Medjo B, Viola M, Nestorovic B, Romano A. Tolerability of meropenem in children with IgE-mediated hypersensitivity to penicillins. Allergy 2008 63 : 237 240.
24. Padial A, Antunez C, Blanca-Lopez N, Fernandez TD, Cornejo-Garcia JA, Mayorga C et al. Non-immediate reactions to beta-lactams: diagnostic value of skin testing and drug provocation test. Clin Exp Allergy 2008 38 : 822 828.
25. Torres M et al. Update on the evaluation of hypersensitivity reactions to betalactams. Allergy 2009 64 : 183 193.
26. Beeler A, Zaccaria L, Kawabata T, Gerber BO, Pichler WJ. CD69 upregulation on T cells as an in vitro marker for delayed-type drug hypersensitivity. Allergy 2008 63 : 181 188.
27. Brockow K et al. Skin testing in patients with hypersensitivity reactions to iodinated contrast media - a European multicenter study. Allergy 2009 64 : 234 241.
28. Benahmed S, Picot MC, Dumas F, Demoly P. Accuracy of a pharmacovigilance algorithm in diagnosing drug hypersensitivity reactions. Arch Intern Med 2005 165 : 1500 1505.
29. Van Cauwenberge P, Watelet JB, Van Zele T, Bousquet J, Burney P, Zuberbier T. Spreading excellence in allergy and asthma: the GA2 LEN (Global Allergy and Asthma European Network) project. Allergy 2005 60 : 858 864.
30. Makowska JS, Grzegorczyk J, Bienkiewicz B, Wozniak M, Kowalski ML. Systemic responses after bronchial aspirin challenge in sensitive patients with asthma. J Allergy Clin Immunol 2008 121 : 348 354.
31. Dursun AB, Woessner KA, Simon RA, Karasoy D, Stevenson DD. Predicting outcomes of oral aspirin challenges in patients with asthma, nasal polyps, and chronic sinusitis. Ann Allergy Asthma Immunol 2008 100 : 420 425.
32. Fraj J, Valero A, Vives R, Perez I, Borja J, Izquierdo I et al. Safety of triflusal (antiplatelet drug) in patients with aspirin-exacerbated respiratory diseases. Allergy 2008 63 : 112 115.
33. Koschel D, Cardoso C, Leucht V, Hoffken G. Asthmatic reaction induced by Etoricoxib in a patient with aspirin-sensitive asthma. Allergy 2008 63 : 1093 1094.
34. Rozsasi A, Polzehl D, Deutschle T, Smith E, Wiesmiller K, Riechelmann H et al. Long-term treatment with aspirin desensitization: a prospective clinical trial comparing 100 and 300 mg aspirin daily. Allergy 2008 63 : 1228 1234.
35. Davis CM, Shearer WT. Diagnosis and management of HIV drug hypersensitivity. J Allergy Clin Immunol 2008 121 : 826 832.e5.
36. Simon MR, Mulla ZD. A population-based epidemiologic analysis of deaths from anaphylaxis in Florida. Allergy 2008 63 : 1077 1083.
37. de Silva IL, Mehr SS, Tey D, Tang ML. Paediatric anaphylaxis: a 5 year retrospective review. Allergy 2008 63 : 1071 1076.
38. Kemp SF, Lockey RF, Simons FE. Epinephrine: the drug of choice for anaphylaxis. A statement of the World Allergy Organization. Allergy 2008 63 : 1061 1070.
39. Simons FE, Frew AJ, Ansotegui IJ, Bochner BS, Golden DB, Finkelman FD et al. Practical allergy (PRACTALL) report: risk assessment in anaphylaxis. Allergy 2008 63 : 35 37.
40. Sheikh A et al. Adrenaline (epinephrine) for the treatment of anaphylaxis: Cochrane systematic review. Allergy 2009 64 : 204 212.
41. Bousquet J, Bieber T, Fokkens W, Kowalski ML, Humbert M, Niggemann B et al. Important questions in allergy: novel research areas. Allergy 2008 63 : 143 147.
42. Demoly P, Pichler W, Pirmohamed M, Romano A. Important questions in Allergy: 1 - drug allergy/hypersensitivity. Allergy 2008 63 : 616 619.
43. Dibbern DA Jr., Montanaro A. Allergies to sulfonamide antibiotics and sulfur-containing drugs. Ann Allergy Asthma Immunol 2008 100 : 91 100 quiz 3, 11.
44. Mitka M. Emergency departments see high rates of adverse events from antibiotic use. JAMA 2008 300 : 1505 1506.